Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Support Care Cancer. 2017 Aug 28;26(2):575–583. doi: 10.1007/s00520-017-3869-3

Table 3.

Longitudinal measures (N = 20)

Instrument Domain Tl T2 T3 T4
M (SD) M (SD) M (SD) M (SD) F df p Partial eta2
HSCS Memory 15.44 (10.41) 13.06 (7.48) 14.19 (11.10) 0.91 2,30 .41 0.054
Language 2.63 (2.80) 1.63 (2.63) 2.44 (3.71) 0.89 2,30 .42 0.056
Attention 0.50 (0.63) .56 (.73) .94 (1.40) 0.8 1.47,21.99 .46 0.051
Self-regulation and planning 2.94 (2.18) 1.94 (1.65) 1.25 (1.61) 4.42 4.42 1.16, 17.31 .046 0.227
Visual/motor 0.20 (.41) .20 (.41) 0 (0) 2.47 2,28 .1 0.5
Spatial 0.53 (0.64) .53 (.74) .40 (1.30) 0.102 1.27, 17.83 .81 0.007
Total score 21.56 (11.25) 17.44 (9.06) 10.69 (13.10) 1.72 2,30 .196 0.103
CDS 24.2 (15.13) 23.2 (15.84) 28.2 (15.11) 25.8 (14.92) 0.86 1.9,28.78 .428 0.54
BCPT Cognitive problems 0.68 (.66) .85 (.72) 1.3 (.80) .83 (.70) 4.54 3,45 .007 0.23
BDI Total score 7.81 (5.06) 9.94 (7.0) 12.5 (7.69) 9.31 (6.59) 4.84 1.98,20.68 .015 0.244
BFI Global score 2.40 (1.95) 3.33 (2.49) 3.78 (2.60) 1.90 (1.81) 6.86 .98,31.67 .003 0.3
CES-D 13.5 (10.98) 13.69 (12.18) 16.13 (9.63) 18.25 (6.68) 1.96 3,45 .134 0.116
MOS-SF36 PCS 50.64 (8.38) 47.39 (11.14) 46.18 (9.95) 56.05 (12.43) 4.01 .91, 19.05 .037 0.286
MCS 48.48 (10.59) 50.10 (10.26) 47.01 (10.28) 52.16 (9.92) 1.41 3,39 .256 0.098
Estradiol level 65.35 (27.61) 41.12 (16.08) 28.68 (10.93) 27.96 1.41,26.83 .001 .595

HSCS High Sensitivity Cognitive Screen, CDS Cognitive Difficulties Scale, BCPT Breast Cancer Prevention Trial, BDI Beck Depression Inventory, BFI Brief Fatigue Index, CES-D Center for Epidemiologic Studies Depression Scale, MOSSF36 Medical Outcome Study Short Form 36, PCS Physical Component Score, MCS Mental Component Score